IP Library Granted Patent US 9,138,308
Granted Patent B2
US 9,138,308 · App. 13/565,670 · Granted Sep 22, 2015

Mucosal tissue adhesion via textured surface

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,138,308
App. No.
13/565,670
Granted
Sep 22, 2015
Kind
B2
Abstract

The present specification discloses porous materials, methods of forming such porous material, biocompatible implantable devices comprising such porous materials, and methods of making such biocompatible implantable devices. The porous material may be used to fix to the interior mucosal lining of a patient's gastrointestinal tract.

Claims (19)

1. A method for anchoring an implant device to a mucosal lining of a patient's gastrointestinal tract comprising:

inserting a pre-formed implant device into the patient's gastrointestinal lumen, which defines a passage that allows for passage therethrough of the pre-formed implant and food, at least a portion of the implant device being formed of a substantially non-resorbable, biocompatible, elastomer matrix defining an array of interconnected pores structured to receive tissue ingrowth from the mucosal lining of the patient's gastrointestinal lumen to anchor the implant device to the mucosal lining; and

placing the implant device within the passage defined by the patient's gastrointestinal lumen such that the array of interconnected pores contacts the mucosal lining such that the implant rests against the mucosal lining and extends into the passage defined by the gastrointestinal lumen and receives tissue ingrowth from the mucosal lining to anchor the implant device to the mucosal lining.

2. The method of claim 1 , wherein the step of placing includes pressing the array of interconnected pores against the mucosal lining.

3. The method of claim 1 , wherein the step of inserting includes inserting the implant device into the patient's gastrointestinal tract with an endoscopic device.

4. The method of claim 1 , wherein the step of inserting includes inserting the implant device into the patient's esophagus through the patient's mouth or inserting the implant device into the patient's large intestine through the patient's anus.

5. The method of claim 1 , wherein the step of placing includes suturing the implant device to the patient's gastrointestinal tract such that the array of interconnected pores contacts the mucosal lining.

6. The method of claim 1 , wherein the array of interconnected pores forms an outer surface of the implant device.

7. The method of claim 1 , wherein each of the pores of the array of interconnected pores has a size of between about 30 microns to about 1000 microns.

8. The method of claim 1 , wherein the elastomer matrix has a porosity of between about 10% to about 80%.

9. The method of claim 1 , wherein the elastomer matrix is a silicone-based elastomer matrix.

10. The method of claim 1 , wherein the implant device is selected from a group consisting of a stent, a drug elution device, a tissue graft, an intragastric volume occupying device, a sensor, a device structured to form a stoma within the gastrointestinal tract, and combinations thereof.

11. A method for anchoring an implant device to a mucosal lining of a patient's gastrointestinal tract comprising:

inserting a pre-formed implant device into the patient's gastrointestinal lumen, which defines a passage that allows for passage therethrough of the pre-formed implant and food, at least a portion of the implant device being formed of a substantially non-resorbable, biocompatible, elastomer matrix defining an array of interconnected pores structured to receive tissue ingrowth from the mucosal lining of the patient's gastrointestinal lumen to anchor the implant device to the mucosal lining; and

placing the implant device within the passage defined by the patient's gastrointestinal lumen such that the array of interconnected pores contacts the mucosal lining such that the implant does not extend into the mucosal lining and receives tissue ingrowth from the mucosal lining to anchor the implant device to the mucosal lining.

12. The method according to claim 11 , wherein the implant is placed such that it does not pass through a surface of the mucosal lining.

13. A method for anchoring an implant device to a mucosal lining of a patient's gastrointestinal tract comprising:

inserting a pre-formed implant device into the patient's gastrointestinal lumen, which defines a passage that allows for passage therethrough of the pre-formed implant and food, without cutting any tissue of the patient, at least a portion of the implant device being formed of a substantially non-resorbable, biocompatible, elastomer matrix defining an array of interconnected pores structured to receive tissue ingrowth from the mucosal lining of the patient's gastrointestinal lumen to anchor the implant device to the mucosal lining; and

placing the implant device within the passage defined by the patient's gastrointestinal lumen such that the array of interconnected pores contacts the mucosal lining and receives tissue ingrowth from the mucosal lining to anchor the implant device to the mucosal lining.

Assignments (15)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2023
From: APOLLO ENDOSURGERY, INC
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 066142/0596 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2023
From: APOLLO ENDOSURGERY US, INC.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 066142/0705 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 5, 2023
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; LPATH THERAPEUTICS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 063264/0046 →
RELEASE OF SECURITY INTEREST Recorded Dec 30, 2021
From: SLR INVESTMENT CORP. (F/K/A SOLAR CAPITAL LTD.)
To: APOLLO ENDOSURGERY US, INC.; APOLLO ENDOSURGERY INTERNATIONAL, LLC; APOLLO ENDOSURGERY, INC.; LPATH THERAPEUTICS INC.
Reel/Frame 058599/0297 →
SECURITY INTEREST Recorded Dec 23, 2021
From: APOLLO ENDOSURGERY, INC.; APOLLO ENDOSURGERY US, INC. (F/K/A LPATH, INC.)
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 058980/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 15, 2019
From: APOLLO ENDOSURGERY US, INC.
To: SOLAR CAPITAL LTD., AS COLLATERAL AGENT
Reel/Frame 048885/0687 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 18, 2019
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: APOLLO ENDOSURGERY US, INC. (F/K/A APOLLO ENDOSURGERY, INC.)
Reel/Frame 048622/0328 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Mar 18, 2019
From: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
To: APOLLO ENDOSURGERY US, INC. (F/K/A APOLLO ENDOSURGERY, INC.)
Reel/Frame 048622/0343 →
CHANGE OF NAME Recorded Mar 27, 2017
From: APOLLO ENDOSURGERY, INC.
To: APOLLO ENDOSURGERY US, INC.
Reel/Frame 042106/0912 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Dec 30, 2016
From: APOLLO ENDOSURGERY US, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 041224/0821 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 2, 2015
From: APOLLO ENDOSURGERY, INC.
To: ATHYRIUM OPPORTUNITIES II ACQUISITION LP, AS ADMINISTRATIVE AGENT
Reel/Frame 035120/0843 →
TERMINATION OF PATENT SECURITY INTEREST (RECORDED ON 12/3/13 AT REEL/FRAME 031756/0729 AND ON 1/2/14 AT REEL/FRAME 031910/0460) Recorded Mar 2, 2015
From: OXFORD FINANCE LLC, AS AGENT
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 035120/0740 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2015
From: SCHWAB, JUSTIN; RAVEN, JOSEPH; LIU, FUTIAN
To: ALLERGAN, INC.
Reel/Frame 035041/0227 →
SECURITY AGREEMENT Recorded Dec 3, 2013
From: APOLLO ENDOSURGERY, INC.
To: OXFORD FINANCE LLC, AS AGENT
Reel/Frame 031756/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2013
From: ALLERGAN, INC.
To: APOLLO ENDOSURGERY, INC.
Reel/Frame 031747/0761 →